- Home
- ALT vs ACNB Comparison
ALT vs ACNB Comparison
Compare ALT & ACNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ALT | ACNB |
|---|---|---|
| Founded | 1997 | 1857 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 415.3M | 468.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ALT | ACNB |
|---|---|---|
| Price | $3.61 | $48.43 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 2 |
| Target Price | $16.33 | ★ $49.50 |
| AVG Volume (30 Days) | ★ 4.8M | 27.3K |
| Earning Date | 11-06-2025 | 01-22-2026 |
| Dividend Yield | N/A | ★ 3.10% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.34 |
| Revenue | $20,000.00 | ★ $136,676,000.00 |
| Revenue This Year | N/A | $41.56 |
| Revenue Next Year | N/A | $4.18 |
| P/E Ratio | ★ N/A | $14.69 |
| Revenue Growth | N/A | ★ 28.45 |
| 52 Week Low | $2.90 | $35.70 |
| 52 Week High | $7.83 | $53.41 |
Technical Indicators
Market Signals| Indicator | ALT | ACNB |
|---|---|---|
| Relative Strength Index (RSI) | 31.65 | 42.40 |
| Support Level | $3.83 | $48.87 |
| Resistance Level | $5.37 | $53.41 |
| Average True Range (ATR) | 0.33 | 1.11 |
| MACD | -0.19 | -0.50 |
| Stochastic Oscillator | 0.82 | 2.85 |
Price Performance
Historical ComparisonAbout ALT Altimmune Inc.
Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.
About ACNB ACNB Corporation
ACNB Corp provides banking, insurance, and financial services to businesses and consumers, through its wholly-owned subsidiaries, ACNB Bank and ACNB Insurance Services, Inc. The corporation has two reporting segments; the Banking segment which generates the majority of the revenue from banking and wealth management services, including trust and retail brokerage, and ACNB Insurance Services segment which offers a broad range of property and casualty, life and health insurance to both commercial and individual clients.